These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 4337586

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clinical significance of circulating proinsulin.
    Gutman RA, Recant L.
    Med Ann Dist Columbia; 1971 Sep; 40(9):589-97. PubMed ID: 4331153
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Editorial: Streptozotocin for islet-cell carcinoma.
    Lancet; 1973 Nov 10; 2(7837):1063-4. PubMed ID: 4127316
    [No Abstract] [Full Text] [Related]

  • 25. The circulating proinsulin-like components.
    Gorden P, Roth J, Freychet P, Kahn R.
    Diabetes; 1972 Nov 10; 21(2 Suppl):673-7. PubMed ID: 4341002
    [No Abstract] [Full Text] [Related]

  • 26. Circulating proinsulin-like material in patients with functioning insulinomas.
    Gutman RA, Lazarus NR, Penhos JC, Fajans S, Recant L.
    N Engl J Med; 1971 May 06; 284(18):1003-8. PubMed ID: 4324225
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Proinsulin and insulin content of subcellular fractions from an islet adenoma.
    Lindall AW, Wong ET, Sorenson RL, Steffes MW.
    J Clin Endocrinol Metab; 1972 Apr 06; 34(4):718-29. PubMed ID: 4335108
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of malignant insulinoma with Streptozotocin.
    Smith CK, Stoll RW, Vance J, Ricketts H, Williams RH.
    Diabetologia; 1971 Apr 06; 7(2):118-24. PubMed ID: 4325749
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Adriamycin therapy for advanced insulinoma.
    Eastman RC, Come SE, Strewler GJ, Gorden P, Kahn CR.
    J Clin Endocrinol Metab; 1977 Jan 06; 44(1):142-8. PubMed ID: 188859
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Insulinoma resection facilitated by the artificial endocrine pancreas.
    Kudlow JE, Albisser AM, Angel A, Langer B, Yip CC, Zinman B, Stokes E.
    Diabetes; 1978 Jul 06; 27(7):774-7. PubMed ID: 207611
    [No Abstract] [Full Text] [Related]

  • 37. The use of artificial beta cell in diagnosis and treatment of insulinoma.
    Raptis S, Zoupas C, Dimitriadis G, Moulopoulos S.
    Horm Metab Res Suppl; 1979 Jul 06; (8):169-72. PubMed ID: 231567
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [An adenoma of the islands of Langerhans producing hypoglycemia and normal blood insulin activity when determined by radioimmunoassay of peripheral and portal blood, but having elevated insulin-like activity in portal blood only (proceedings)].
    Mirouze J, Marchal G, Orsetti A, Baldet P, Piperno M, Monnier L, Jaffiol C, Hedon L.
    Diabete Metab; 1976 Sep 06; 2(3):148. PubMed ID: 188700
    [No Abstract] [Full Text] [Related]

  • 40. Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.
    Duckworth WC, Solomon SS, Kitabchi AE.
    J Clin Endocrinol Metab; 1972 Oct 06; 35(4):585-91. PubMed ID: 5052977
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.